Digital technology’s presence in the healthcare industry continues to grow, expanding across diagnostic and therapeutic treatments in precision medicine. Biorasi was on-site to witness these advancements and innovations at this year’s Molecular Med Tri-Con.
With digital therapeutics experiencing an evolution, Biorasi was on hand at DTx West 2020 to highlight the importance of evidence as a differentiator in clinical trials. Read more about our event experience >>
Biorasi will be at the 2019 Orphan Drugs and Rare Diseases 2019 Americas – West Coast from July 23rd - 24th 2019 in San Francisco, CA, USA. We would like to extend a cordial invitation to all of our partners, sponsors, and friends to come talk to us!. We will be showcasing how Biorasi is a new kind of CRO in how we manage clinical trials, as well as providing information on our Rare Disease Study expertise.
Biorasi will be attending and exhibiting at the SCOPE 2019 Annual Meeting from February 18-21 in […]
Biorasi will be attending and exhibiting at the BIO 2019 conference from June 3-6 in Philadelphia, […]
Biorasi will be attending and exhibiting at the DIA 2019 Global Annual Meeting from June 23-27 […]
Biorasi will be attending and exhibiting at the Immuno-Oncology 2019 summit from August 5-9 in Boston, […]
Biorasi will be attending World ADC 2019 from October 10-11 in San Diego, CA. We would […]
Biorasi will be attending CNS Summit 2019 from October 31 – November 3 in Boca Raton, […]
Biorasi will be attending and exhibiting at the Kidney Week 2019 conference from November 5-10 in […]
